Skip to main content

Table 2 Risk variants validated in Parkinson’s disease in Chinese population

From: Parkinson’s disease in China: a forty-year growing track of bedside work

Models

Polymorphisms

Allele

A2M rs669; A2M rs3832852; BST1 rs4698412; BST1 rs11931532; CHCHD2 rs142444896; CCDC62/HIP1R rs12817488; GAK/PARK17 rs1564282; GBA L444P; GPNMB rs156429; LINGO1 rs11856808; LRRK2 rs34594498; LRRK2 rs34778348; LRRK2 rs33949390; LRRK2 rs7304279; LRRK2 rs2046932; NUCKS1 rs823114; PARK16 rs823156; PITX3 rs3758549; SIPA1L2 rs10797576; PARK16 rs947211; RIT2 rs12456492; NQO1 C609T; SNCA rs11931074; SNCA rs2736990; SNCA rs356165; SNCA rs356219; SNCA rs3822086;

Dominant

A2M rs669; BST1 rs4698412; CHCHD2 rs142444896; CCDC62/HIP1R rs12817488; GAK/PARK17 rs1564282; GBA L444P; GPNMB rs156429; LINGO1 rs11856808; LRRK2 rs34594498; LRRK2 rs34778348; LRRK2 rs33949390; PITX3 rs2281983; PITX3 rs3758549; PITX3 rs4919621; SIPA1L2 rs10797576; PARK16 rs947211; RIT2 rs12456492; SLC41A1 rs11240569; SNCA rs11931074; SNCA rs2736990; SNCA rs356165; SNCA rs356219; SNCA rs3822086;

Recessive

BST1 rs4698412; BST1 rs11931532; CCDC62/HIP1R rs12817488; GAK/PARK17 rs1564282; LRRK2 rs7304279; LRRK2 rs2046932; NUCKS1 rs823114; PARK16 rs823156; PARK16 rs947211; SNCA rs11931074; SNCA rs2301135; SNCA rs2736990; SNCA rs356165; SNCA rs356219; SNCA rs3822086;

Overdominant

A2M rs669; CHCHD2 rs142444896; GAK/PARK17 rs1564282; GBA L444P; GPNMB rs156429; LINGO1 rs11856808; LRRK2 rs34594498; LRRK2 rs34778348; LRRK2 rs33949390; LRRK2 rs7304279; LRRK2 rs2046932; NUCKS1 rs823114; PARK16 rs823156; PITX3 rs2281983; PITX3 rs3758549; SIPA1L2 rs10797576; VPS13C rs2414739; SLC41A1 rs11240569; SNCA rs11931074; SNCA rs356165;